Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways

Saurabh Rajpal, Rami Kahwash, Matthew S. Tong, Kelly Paschke, Anjali A. Satoskar, Beth Foreman, Larry A. Allen, Nicole M. Bhave, Ty J. Gluckman, Valentin Fuster

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter-defibrillator and antiarrhythmic drug therapy.

Original languageEnglish
Pages (from-to)567-575
Number of pages9
JournalJACC: Case Reports
Issue number10
StatePublished - 18 May 2022


  • COVID-19
  • fulminant myocarditis
  • ventricular arrhythmias


Dive into the research topics of 'Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways'. Together they form a unique fingerprint.

Cite this